Healthcare -
Biotechnology - NASDAQ - US
$ 690.89
-1.12 %
$ 74.3 B
Market Cap
18.01
P/E
REGN - RETAINED EARNINGS
Retained Earnings REGN - Regeneron Pharmaceuticals, Inc.
31.7 B
LAST VALUE
16.57%
2 YEAR CAGR
33.82%
5 YEAR CAGR
61.94%
10 YEAR CAGR